Life Sciences
Massachusetts Life Sciences Industry: Leading Indicators
The life sciences industry and Massachusetts are synonymous, and the state has become known as the world’s leading life sciences supercluster. Companies relocate from across the world so they can be among the best biotech, pharma, and healthcare organizations here in the Commonwealth. Massachusetts boasts over 35 million SF of commercial biopharma space and has 700k liters of biomanufacturing capacity, which is the most in the world.
Massachusetts is home to 1,200 life sciences companies including top employers Takeda, Sanofi, and Fresenius. Massachusetts life sciences employees total around 120k. In addition, Massachusetts is number one in the National Institutes of Health per capita funding and number one in Medical Device Exports as percentage of all exports. In 2020, Massachusetts companies received $5.8 billion in Venture Capital funding. $1.5 billion in Massachusetts Life Sciences Initiative Incentives also make the state an attractive place for life sciences companies.
More leading indicators:
- #1 in National Institutes of Health per capita funding
- #1 in Medical Device Exports as percentage of all exports
- $5.8 billion in Venture Capital funding in 2020
- $1.5 billion in Massachusetts Life Sciences Initiative Incentives
2023 Corporate Welcome Honoree: Akari Therapeutics (Boston)
Massachusetts Leading Life Sciences Employers:
No Data Found
Massachusetts Life Sciences Industry News
Recent Posts
Indianapolis-based pharmaceutical giant Eli Lilly & Co. has unveiled plans for a $700 million institute for genetic medicine in Boston’s Seaport District. The opening is slated for 2024. The company has signed a 334,000-square-foot lease at 15 Necco St., a 12-story healthcare and life sciences building.
Shanghai-based Zai Lab Limited is expanding its Cambridge headquarters as it looks to become an international pharma giant.
an organ editing metabolic therapeutics company pioneering a new approach to the treatment of type 2 diabetes, will re-locate its operations from Lexington to Burlington, with an anticipated occupancy of Q4 2023.
Biopharmaceutical company Ventus Therapeutics, which is utilizing structural biology and a proprietary computational chemistry platform to identify and develop small molecule therapeutics across a broad range of diseases, opened a 13K SF office and lab facility in Waltham as the first phase of its planned global expansion.
Pharmaceutical company Thermo Fisher Scientific celebrated the official opening of its 289,416 SF building in Plainville. The state-of-the-art facility will add approximately 300 jobs to support the development, testing, and manufacturing of viral vectors.
Minnesota-based Trelleborg Healthcare & Medical is expand its manufacturing facility and BioPharma Center of Excellence in Northborough. The three-phase expansion project is expected to create at least 50 new jobs and phase one should commence in January 2023.
Pharmaceutical company Servier Pharmaceuticals unveiled its cancer-focused R&D campus in Boston's Seaport neighborhood.
Pharmaceutical company Bayer AG opened its new 62,100 SF Research and Innovation Center in Cambridge's Kendall Square, representing a $140 million investment.
Drugmaker Takeda is leasing 600K SF at a building under development in Cambridge's Kendall Square.
Biotechnology company Enanta signed a new lease to take lab-and-office space at a future building at Alexandria Real Estate Equities Inc.’s Arsenal on the Charles campus in Watertown.
Accent Therapeutics, which works to provide therapies to cancer patients, leased 65,003 SF in Lexington.
COVID-19 vaccine creator, Moderna, Inc., received a $2.325 million LSI incentive and TIF agreement valued at $9.1 million. The Norwood company committed to hiring at least 155 new Massachusetts-based employees for high-tech manufacturing positions in 2021 and retaining through 2025.
Bristol Myers Squibb to build 244,000 SF cell therapy manufacturing facilities at Devens and add over 300 jobs.
BioMed Realty announced a major acquisition of property at Assembly Square in Somerville, at which it will build a multi-phased, 1.3 million square foot campus. The site, well-connnected by infrastructure to nearby Boston and Cambridge, is envisioned as a bet-in-class, purpose build innovation space for research, technology, and life science tenants.
Lykan Bioscience, an emerging manufacturer of clinical products to provide solutions in cell and gene therapy manufacturing, has moved into its new facility in Hopkinton. The company conducted a site search in MA and out-of-state and identified a viable location in Hopkinton. The project consists of lease and renovation of a vacant, 63,000 sq. ft. building to create a state-of-the-art clinical manufacturing facility. The company has created 125 new jobs and made a private investment of $12 million. The town of Hopkinton approved a 10-year TIF agreement valued at approximately $416,788 to support the project.
In Plainville, Mass., Thermo Fisher Scientific is building a 290,000-square-foot manufacturing facility, which will be the largest viral vector manufacturing facility in North America. The $190 million facility will be completed in 2222 and create more than 200 jobs.
At MassEcon, Location is Everything!
To start your customized site search, start here and contact Doug Kehlhem, Senior Director, MassEcon, Dkehlhem@massecon.com, 617-9244-600, x112. Or, submit an on-line search request here
